End-Stage Kidney Disease (ESKD), Chronic Kidney Disease (CKD) Progression and Mortality among a Racially/Ethnically Diverse Population with Primary Immunoglobulin A Nephropathy (IgAN).
Incidence of Primary Immunoglobulin A Nephropathy (IgAN) among a Racially/Ethnically Diverse Population in USA during 2010-2021
Sibeprenlimab in patients with IgA nephropathy: a Phase 2 trial.
Evaluation of Tolvaptan Effect in Autosomal Dominant Polycystic Kidney Disease (ADPKD) Using Inverse Probability of Censoring Weighting for Long-term Extension Data.
Liver Safety of Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD): Interim Data from an EU Post-authorization Safety Study (EUPASS).
Previous
Next
